Latest stock market podcasts

Bell Direct

March 20, 2026

In this episode of From the Helm, Grady chats with Alterity Therapeutics (ASX:ATH) CEO David Stamler, to discuss their neurodegenerative disorder treatment specifically targeting Multiple System Atrophy (MSA), a rare and aggressive disease affecting involuntary functions and motor control.

Market Update 26 February

Bell Direct

February 26, 2020

Morning Bell 24 February

Bell Direct

February 23, 2020

Morning Bell 21 February

Bell Direct

February 20, 2020

From the helm: CSL's David Lamont on the biotech giant's bright future

Bell Direct

February 20, 2020

Morning Bell 20 February

Bell Direct

February 19, 2020

Morning Bell 19 February

Bell Direct

February 18, 2020

Morning Bell 18 February

Bell Direct

February 17, 2020

Morning Bell 17 February

Bell Direct

February 16, 2020

Weekly Wrap 14 February

Bell Direct

February 14, 2020

Morning Bell 14 February

Bell Direct

February 13, 2020

From the helm: Brickworks' Lindsay Partridge

Bell Direct

February 12, 2020

Morning Bell 11 February

Bell Direct

February 10, 2020